The collaboration with Carl Zeiss to jointly develop a rigid endoscope to be sold by them under their brand is supposed to contain $4M worth of milestone payments.
Most recently Optiscan received Euro 180K. And I see A$371K in FY13 and A$1.3M in FY11.
If the math is that simple then it means there may be another A$2M in milestone payments to be received by final product launch. Plus there should be many $millions in sales of units to Zeiss to kick start their inventory. The original deal spoke of $20M including the $4M milestone payments. Zeiss probably haven't bought half of the expected $16M over the years (I see over $5M of sales booked one year but nothing else).
Of course I'm expecting further delays beyond this calendar year because that's been the pattern so far , but WHEN it happens there may be some very significant revenue compared to the market cap.
Investing and analysing companies is not my field so I'm happy to stand corrected. I won't take offense if you show I am talking crap.
Add to My Watchlist
What is My Watchlist?
